US Patent Issued to Siemens Healthcare Diagnostics on March 25 for "Methods and compositions for removing biotin interference from assays using molecular traps" (Delaware, Pennsylvania Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,259,381, issued on March 25, was assigned to Siemens Healthcare Diagnostics Inc. (Tarrytown, N.Y.).

"Methods and compositions for removing biotin interference from assays using molecular traps" was invented by Tie Wei (Wilmington, Del.), Zhu Teng (Garnet Valley, Pa.) and Izak Bahar (Hockessin, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions to remove or reduce biotin interference from certain assays."

The patent was filed on Sept. 19, 2019, under Application No. 17/250,609.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...